Knowledge of thresholds constitutes a critical requirement to assessing the risk from allergens, as they are a characteristic of the hazard that allergens present to the food-allergic population. An expert committee of The Food and Agriculture Organization (FAO) concurred that

More than half of food recalls in the United Kingdom over a 5-year period were due to allergens, according to a recently released study. Allergen-related recalls increased annually until 2019, peaking at 118 before decreasing to 82 and 84 in

This review explores the Health Related Quality of Life (HRQL) in allergic patients suffering from food and venom allergy, both being the most frequent causes of serious allergy and potential life-threatening reactions.

Aimmune Therapeutics has shared its positive findings from the Phase 3 POSEIDON study of Palforzia.  

The aim of this study was to assess the impact anaphylaxis has on the QoL and mental health of adults, using validated measures. 

Specifically, the article predicts that biologics may play a key role in the therapeutic options available and that identifying reliable biomarkers and developing standardised approaches could lead to individualised approaches to managing food allergy. 

The study explored the impact of COVID-19 on children with serious allergies.

The high prevalence of legume sensitisation and the frequent serious reactions reported in children with peanut allergy highlight that tolerated legume consumption should be explored for each legume in the case of peanut allergy.  

Allergy to cow’s milk is the most common food allergy affecting children. There is currently no accepted routine clinical therapy to cure milk allergy.